Mike Austin

Prior to his appointment at Cobra in April 2020, Mike held the role of General Manager Biologics - Astra Zeneca Sweden.

Mike was accountable at a senior level for leading and realising the company’s significant Drug Product investment at their Södertälje campus – from ground breaking to realisation.

As an experienced Operations Biotech Executive, Mike formerly held senior leadership roles in a number of growing biotech and world class biopharmaceutical companies , including Astra Zeneca, Medimmune, Serologicals, Johnson & Johnson and 3M Healthcare.